Jan 28, 2025, 09:09
Myriam Chalabi: Long awaited practice-changing results from phase 3 CM8HW are out
Myriam Chalabi, Medical Oncologist and Cancer Immunotherapy researcher in Gastrointestinal Oncology at Antoni van Leeuwenhoek, The Netherlands Cancer Institute (NKI), recently shared an article she and her colleagues authored on X:
“Long awaited practice-changing results from ph 3 CM8HW now out in The Lancet. Nivo/ipi sign better than nivo mono in dMMR mCRC.”
Authors: Thierry André et al.
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Jan 28, 2025, 09:02
Jan 28, 2025, 09:01
Jan 28, 2025, 08:52